Selected research
Market Analysis & Forecast
Global Vitamin and Derivative Market Analysis and Forecast 2026-2032
Market perspective
The global Vitamin and Derivative market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Vitamin and Derivative is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Vitamin and Derivative is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Vitamin and Derivative is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Vitamin and Derivative is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Vitamin and Derivative include Lonza Group, Pfizer, Bayer, ParkAcre Enterprises, Nutrilo, DuPont, DSM, BASF and Amway, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Vitamin and Derivative, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Vitamin and Derivative, also provides the sales of main regions and countries. Of the upcoming market potential for Vitamin and Derivative, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vitamin and Derivative sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Vitamin and Derivative market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Vitamin and Derivative sales, projected growth trends, production technology, application and end-user industry.
Vitamin and Derivative Segment by Company
Lonza Group
Pfizer
Bayer
ParkAcre Enterprises
Nutrilo
DuPont
DSM
BASF
Amway
Aland Nutraceutical
AIE Pharmaceuticals
Adisseo France S.A.A
Vitamin and Derivative Segment by Type
Vitamin and Derivative Capsules
Vitamin and Derivative Powder
Vitamin and Derivative Tablets
Vitamin and Derivative Segment by Application
Pharmaceuticals
Food and Beverages
Dietary Supplements
Personal Care
Others
Vitamin and Derivative Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamin and Derivative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vitamin and Derivative and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamin and Derivative.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Vitamin and Derivative in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Vitamin and Derivative manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vitamin and Derivative sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vitamin and Derivative Capsules
- Vitamin and Derivative Powder
- Vitamin and Derivative Tablets
Applications
- Pharmaceuticals
- Food and Beverages
- Dietary Supplements
- Personal Care
- Others
Companies covered
- Lonza Group
- Pfizer
- Bayer
- ParkAcre Enterprises
- Nutrilo
- DuPont
- DSM
- BASF
- Amway
- Aland Nutraceutical
- AIE Pharmaceuticals
- Adisseo France S.A.A
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Vitamin and Derivative Market by Type
- 1.2.1 Global Vitamin and Derivative Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Vitamin and Derivative Capsules
- 1.2.3 Vitamin and Derivative Powder
- 1.2.4 Vitamin and Derivative Tablets
- 1.3 Vitamin and Derivative Market by Application
- 1.3.1 Global Vitamin and Derivative Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceuticals
- 1.3.3 Food and Beverages
- 1.3.4 Dietary Supplements
- 1.3.5 Personal Care
- 1.3.6 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Vitamin and Derivative Market Dynamics
- 2.1 Vitamin and Derivative Industry Trends
- 2.2 Vitamin and Derivative Industry Drivers
- 2.3 Vitamin and Derivative Industry Opportunities and Challenges
- 2.4 Vitamin and Derivative Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Vitamin and Derivative Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Vitamin and Derivative Revenue by Region
- 3.2.1 Global Vitamin and Derivative Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Vitamin and Derivative Revenue by Region (2021-2026)
- 3.2.3 Global Vitamin and Derivative Revenue by Region (2027-2032)
- 3.2.4 Global Vitamin and Derivative Revenue Market Share by Region (2021-2032)
- 3.3 Global Vitamin and Derivative Sales Estimates and Forecasts 2021-2032
- 3.4 Global Vitamin and Derivative Sales by Region
- 3.4.1 Global Vitamin and Derivative Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Vitamin and Derivative Sales by Region (2021-2026)
- 3.4.3 Global Vitamin and Derivative Sales by Region (2027-2032)
- 3.4.4 Global Vitamin and Derivative Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Vitamin and Derivative Revenue by Manufacturers
- 4.1.1 Global Vitamin and Derivative Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Vitamin and Derivative Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Vitamin and Derivative Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Vitamin and Derivative Sales by Manufacturers
- 4.2.1 Global Vitamin and Derivative Sales by Manufacturers (2021-2026)
- 4.2.2 Global Vitamin and Derivative Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Vitamin and Derivative Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Vitamin and Derivative Sales Price by Manufacturers (2021-2026)
- 4.4 Global Vitamin and Derivative Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Vitamin and Derivative Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Vitamin and Derivative Manufacturers, Product Type & Application
- 4.7 Global Vitamin and Derivative Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Vitamin and Derivative Market CR5 and HHI
- 4.8.2 2025 Vitamin and Derivative Tier 1, Tier 2, and Tier 3
5 Vitamin and Derivative Market by Type
- 5.1 Global Vitamin and Derivative Revenue by Type
- 5.1.1 Global Vitamin and Derivative Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Vitamin and Derivative Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Vitamin and Derivative Revenue Market Share by Type (2021-2032)
- 5.2 Global Vitamin and Derivative Sales by Type
- 5.2.1 Global Vitamin and Derivative Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Vitamin and Derivative Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Vitamin and Derivative Sales Market Share by Type (2021-2032)
- 5.3 Global Vitamin and Derivative Price by Type
6 Vitamin and Derivative Market by Application
- 6.1 Global Vitamin and Derivative Revenue by Application
- 6.1.1 Global Vitamin and Derivative Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Vitamin and Derivative Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Vitamin and Derivative Revenue Market Share by Application (2021-2032)
- 6.2 Global Vitamin and Derivative Sales by Application
- 6.2.1 Global Vitamin and Derivative Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Vitamin and Derivative Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Vitamin and Derivative Sales Market Share by Application (2021-2032)
- 6.3 Global Vitamin and Derivative Price by Application
7 Company Profiles
- 7.1 Lonza Group
- 7.1.1 Lonza Group Company Information
- 7.1.2 Lonza Group Business Overview
- 7.1.3 Lonza Group Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Lonza Group Vitamin and Derivative Product Portfolio
- 7.1.5 Lonza Group Recent Developments
- 7.2 Pfizer
- 7.2.1 Pfizer Company Information
- 7.2.2 Pfizer Business Overview
- 7.2.3 Pfizer Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Pfizer Vitamin and Derivative Product Portfolio
- 7.2.5 Pfizer Recent Developments
- 7.3 Bayer
- 7.3.1 Bayer Company Information
- 7.3.2 Bayer Business Overview
- 7.3.3 Bayer Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Bayer Vitamin and Derivative Product Portfolio
- 7.3.5 Bayer Recent Developments
- 7.4 ParkAcre Enterprises
- 7.4.1 ParkAcre Enterprises Company Information
- 7.4.2 ParkAcre Enterprises Business Overview
- 7.4.3 ParkAcre Enterprises Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 ParkAcre Enterprises Vitamin and Derivative Product Portfolio
- 7.4.5 ParkAcre Enterprises Recent Developments
- 7.5 Nutrilo
- 7.5.1 Nutrilo Company Information
- 7.5.2 Nutrilo Business Overview
- 7.5.3 Nutrilo Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Nutrilo Vitamin and Derivative Product Portfolio
- 7.5.5 Nutrilo Recent Developments
- 7.6 DuPont
- 7.6.1 DuPont Company Information
- 7.6.2 DuPont Business Overview
- 7.6.3 DuPont Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 DuPont Vitamin and Derivative Product Portfolio
- 7.6.5 DuPont Recent Developments
- 7.7 DSM
- 7.7.1 DSM Company Information
- 7.7.2 DSM Business Overview
- 7.7.3 DSM Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 DSM Vitamin and Derivative Product Portfolio
- 7.7.5 DSM Recent Developments
- 7.8 BASF
- 7.8.1 BASF Company Information
- 7.8.2 BASF Business Overview
- 7.8.3 BASF Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 BASF Vitamin and Derivative Product Portfolio
- 7.8.5 BASF Recent Developments
- 7.9 Amway
- 7.9.1 Amway Company Information
- 7.9.2 Amway Business Overview
- 7.9.3 Amway Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Amway Vitamin and Derivative Product Portfolio
- 7.9.5 Amway Recent Developments
- 7.10 Aland Nutraceutical
- 7.10.1 Aland Nutraceutical Company Information
- 7.10.2 Aland Nutraceutical Business Overview
- 7.10.3 Aland Nutraceutical Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Aland Nutraceutical Vitamin and Derivative Product Portfolio
- 7.10.5 Aland Nutraceutical Recent Developments
- 7.11 AIE Pharmaceuticals
- 7.11.1 AIE Pharmaceuticals Company Information
- 7.11.2 AIE Pharmaceuticals Business Overview
- 7.11.3 AIE Pharmaceuticals Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 AIE Pharmaceuticals Vitamin and Derivative Product Portfolio
- 7.11.5 AIE Pharmaceuticals Recent Developments
- 7.12 Adisseo France S.A.A
- 7.12.1 Adisseo France S.A.A Company Information
- 7.12.2 Adisseo France S.A.A Business Overview
- 7.12.3 Adisseo France S.A.A Vitamin and Derivative Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 Adisseo France S.A.A Vitamin and Derivative Product Portfolio
- 7.12.5 Adisseo France S.A.A Recent Developments
8 North America
- 8.1 North America Vitamin and Derivative Market Size by Type
- 8.1.1 North America Vitamin and Derivative Revenue by Type (2021-2032)
- 8.1.2 North America Vitamin and Derivative Sales by Type (2021-2032)
- 8.1.3 North America Vitamin and Derivative Price by Type (2021-2032)
- 8.2 North America Vitamin and Derivative Market Size by Application
- 8.2.1 North America Vitamin and Derivative Revenue by Application (2021-2032)
- 8.2.2 North America Vitamin and Derivative Sales by Application (2021-2032)
- 8.2.3 North America Vitamin and Derivative Price by Application (2021-2032)
- 8.3 North America Vitamin and Derivative Market Size by Country
- 8.3.1 North America Vitamin and Derivative Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Vitamin and Derivative Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Vitamin and Derivative Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Vitamin and Derivative Market Size by Type
- 9.1.1 Europe Vitamin and Derivative Revenue by Type (2021-2032)
- 9.1.2 Europe Vitamin and Derivative Sales by Type (2021-2032)
- 9.1.3 Europe Vitamin and Derivative Price by Type (2021-2032)
- 9.2 Europe Vitamin and Derivative Market Size by Application
- 9.2.1 Europe Vitamin and Derivative Revenue by Application (2021-2032)
- 9.2.2 Europe Vitamin and Derivative Sales by Application (2021-2032)
- 9.2.3 Europe Vitamin and Derivative Price by Application (2021-2032)
- 9.3 Europe Vitamin and Derivative Market Size by Country
- 9.3.1 Europe Vitamin and Derivative Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Vitamin and Derivative Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Vitamin and Derivative Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Vitamin and Derivative Market Size by Type
- 10.1.1 China Vitamin and Derivative Revenue by Type (2021-2032)
- 10.1.2 China Vitamin and Derivative Sales by Type (2021-2032)
- 10.1.3 China Vitamin and Derivative Price by Type (2021-2032)
- 10.2 China Vitamin and Derivative Market Size by Application
- 10.2.1 China Vitamin and Derivative Revenue by Application (2021-2032)
- 10.2.2 China Vitamin and Derivative Sales by Application (2021-2032)
- 10.2.3 China Vitamin and Derivative Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Vitamin and Derivative Market Size by Type
- 11.1.1 Asia Vitamin and Derivative Revenue by Type (2021-2032)
- 11.1.2 Asia Vitamin and Derivative Sales by Type (2021-2032)
- 11.1.3 Asia Vitamin and Derivative Price by Type (2021-2032)
- 11.2 Asia Vitamin and Derivative Market Size by Application
- 11.2.1 Asia Vitamin and Derivative Revenue by Application (2021-2032)
- 11.2.2 Asia Vitamin and Derivative Sales by Application (2021-2032)
- 11.2.3 Asia Vitamin and Derivative Price by Application (2021-2032)
- 11.3 Asia Vitamin and Derivative Market Size by Country
- 11.3.1 Asia Vitamin and Derivative Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Vitamin and Derivative Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Vitamin and Derivative Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Vitamin and Derivative Market Size by Type
- 12.1.1 SAMEA Vitamin and Derivative Revenue by Type (2021-2032)
- 12.1.2 SAMEA Vitamin and Derivative Sales by Type (2021-2032)
- 12.1.3 SAMEA Vitamin and Derivative Price by Type (2021-2032)
- 12.2 SAMEA Vitamin and Derivative Market Size by Application
- 12.2.1 SAMEA Vitamin and Derivative Revenue by Application (2021-2032)
- 12.2.2 SAMEA Vitamin and Derivative Sales by Application (2021-2032)
- 12.2.3 SAMEA Vitamin and Derivative Price by Application (2021-2032)
- 12.3 SAMEA Vitamin and Derivative Market Size by Country
- 12.3.1 SAMEA Vitamin and Derivative Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Vitamin and Derivative Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Vitamin and Derivative Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Vitamin and Derivative Value Chain Analysis
- 13.1.1 Vitamin and Derivative Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Vitamin and Derivative Production Mode & Process
- 13.2 Vitamin and Derivative Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Vitamin and Derivative Distributors
- 13.2.3 Vitamin and Derivative Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst